The EASE Study - Human Factor and Usability Testing of a Binocular OCT System
EASE
A Prospective Single-Site Non-Interventional Study to Evaluate Human Factors and Usability of Automated, Comprehensive Ocular Examination in Elderly and Visually Impaired Populations Using a Prototype Binocular Optical Coherence Tomography System
1 other identifier
observational
60
1 country
1
Brief Summary
Ophthalmology is among the most technology driven of all medical specialties, with advanced medical imaging devices - and specialised computer software - increasingly adopted for routine clinical use. While many such devices are capable of completing specific tasks, lack of "usability" prevents their widespread adoption (i.e., such devices are not easy to learn and remember, or are not efficient or subjectively pleasing to use). Moreover, devices that are difficult to use expose patients to clinical risk as a result of human error during usage. With the introduction of a new medical technology, it is essential, therefore, to have a deep understanding of patients, what they need, what they value, their abilities, and also their limitations. Human factor and usability testing, also known as "human factor engineering", deals with the formal study of people's interaction with their environment (in this case, the binocular optical coherence tomography (OCT) device). Structured, patient-centred, usability testing is essential to the design, clinical validation, regulatory approval, and widespread implementation, of all new medical devices. This is particularly the case for a putative binocular OCT system - a device intended for automated use in visually impaired, often elderly, populations. Although the binocular OCT is already at an advanced stage of hardware development, the EASE study will facilitate an iterative process of operating software and workflow modifications to optimize the device for use in these populations.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for all trials
Started May 2016
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
May 1, 2016
CompletedFirst Submitted
Initial submission to the registry
June 23, 2016
CompletedFirst Posted
Study publicly available on registry
July 4, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2016
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2016
CompletedResults Posted
Study results publicly available
March 26, 2020
CompletedMarch 26, 2020
March 1, 2020
5 months
June 23, 2016
September 5, 2017
March 25, 2020
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Total Examination Time
Total time for each participant to complete the binocular optical coherence tomography (OCT) examination was calculated.
6 months
Secondary Outcomes (2)
Number of Participants With Subjective Ratings ≥ 4 on Post-Test Questionnaire
6 months
Number of Participants That Presented Gradable Data, by Examination Type
4 months
Study Arms (4)
Retinal Disease
Fifteen subjects with retinal disease. Each participant will attend for a single study visit, lasting approximately 1 hour in duration.
Glaucoma
Fifteen subjects with glaucoma. Each participant will attend for a single study visit, lasting approximately 1 hour in duration.
Strabismus
Fifteen subjects with strabismus. Each participant will attend for a single study visit, lasting approximately 1 hour in duration.
Healthy volunteers
Fifteen healthy volunteers. Each participant will attend for a single study visit, lasting approximately 1 hour in duration.
Interventions
Testing will begin using a prototype binocular OCT system. Subjects will undergo the full suite of diagnostic assessments offered by the system at that time (i.e., visual acuity, ophthalmic history, pupillometry, ocular motility, perimetry, anterior segment and posterior segment OCT imaging).
Eligibility Criteria
Participants with chronic eye disease (retinal disease, glaucoma, and strabismus) will be recruited from appropriate eye clinics at Moorfields Eye Hospital and from a patient advisory group established for this purpose.
You may qualify if:
- Presence of retinal disease, glaucoma or strabismus
- Male or female, aged 18 years or older
- Ability to understand nature/purpose of the study and to provide informed consent
- Ability to undergo binocular OCT imaging
- Ability to follow instructions and complete the study
- Ability to speak English
You may not qualify if:
- Optical media opacity sufficient to preclude adequate ocular imaging with OCT
- Hearing impairment sufficient to interfere with hearing instructions
- Any condition which, in the investigator's opinion, would conflict or otherwise prevent the subject from complying with the required procedures, schedule, or other study conduct.
- No self-reported ocular history (although wearing corrective prescription glasses is permitted)
- Male or female, aged 18 years or older
- Ability to understand nature/purpose of the study and to provide informed consent
- Ability to undergo binocular OCT imaging
- Ability to follow instructions and complete the study
- Ability to speak English
- Presence of ocular pathology
- Hearing impairment sufficient to interfere with hearing instructions
- Any condition which, in the investigator's opinion, would conflict or otherwise prevent the subject from complying with the required procedures, schedule, or other study conduct.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Moorfields Eye Hospital NHS FT
London, EC1V 2PD, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Pearse Keane
- Organization
- Moorfields Eye Hospital NHS Foundation Trust
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- observational
- Observational Model
- CASE ONLY
- Time Perspective
- CROSS SECTIONAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
June 23, 2016
First Posted
July 4, 2016
Study Start
May 1, 2016
Primary Completion
October 1, 2016
Study Completion
October 1, 2016
Last Updated
March 26, 2020
Results First Posted
March 26, 2020
Record last verified: 2020-03